Proacta Company

Proacta is a clinical-stage biopharmaceutical company developing hypoxia-activated ’prodrugs“ for the treatment of cancer.

Founded Date: 2004
Last Funding Type: Debt Financing
Headquarters: La Jolla, California, United States
Investors Number: 7
Technology: Others
Employee Number: 1-10
Industry: PharmTech
Number Of Exists: N/A
Funding Status: Early Stage Venture
Investor Type: N/A
Investment Stage: N/A
Total Funding: $47M